AIM2 and chronic obstructive pulmonary disease: These data may suggest that corticosteroids treatment during hospitalization may increase AIM2 expression, without increasing its activity in that the stimulation of this receptor in a stable condition did not increase IL-1α release in the same manner as observed for exacerbated patients, implying that AIM2 is not active in stable COPD patients.